BIOMAT Database Logo BIOMAT Database Logo

[Modalities of treatment of Parkinsonian syndrome with L-dopa]. 1972

G Yanniotis, and J J Eisenring, and G Gauthier, and R Tissot, and J de Ajuriaguerra

UI MeSH Term Description Entries
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D002262 Carboxy-Lyases Enzymes that catalyze the addition of a carboxyl group to a compound (carboxylases) or the removal of a carboxyl group from a compound (decarboxylases). EC 4.1.1. Carboxy-Lyase,Decarboxylase,Decarboxylases,Carboxy Lyase,Carboxy Lyases
D004295 Dihydroxyphenylalanine A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific. Dopa,3,4-Dihydroxyphenylalanine,3-Hydroxy-DL-tyrosine,Dihydroxyphenylalanine Hydrochloride, (2:1),beta-Hydroxytyrosine,3 Hydroxy DL tyrosine,3,4 Dihydroxyphenylalanine,beta Hydroxytyrosine
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G Yanniotis, and J J Eisenring, and G Gauthier, and R Tissot, and J de Ajuriaguerra
[Treatment of the parkinsonian syndrome with L-dopa and amantadine].
January 1973, Neurologia, psihiatria, neurochirurgia,
G Yanniotis, and J J Eisenring, and G Gauthier, and R Tissot, and J de Ajuriaguerra
[Treatment of parkinsonian states with L-dopa].
November 1971, Bulletin de l'Academie nationale de medecine,
G Yanniotis, and J J Eisenring, and G Gauthier, and R Tissot, and J de Ajuriaguerra
[L-dopa in the treatment of the Parkinsonian syndrome].
January 1973, Neurologia, psihiatria, neurochirurgia,
G Yanniotis, and J J Eisenring, and G Gauthier, and R Tissot, and J de Ajuriaguerra
[Treatment with L-dopa in Parkinsonian syndromes].
January 1970, Sistema nervoso,
G Yanniotis, and J J Eisenring, and G Gauthier, and R Tissot, and J de Ajuriaguerra
Apomorphine SC treatment in parkinsonian patients with long-term L-dopa syndrome during L-dopa drug holiday.
January 1995, Journal of neural transmission. Supplementum,
G Yanniotis, and J J Eisenring, and G Gauthier, and R Tissot, and J de Ajuriaguerra
[Review of problems in the treatment of the parkinsonian syndrome with L-dopa].
March 1976, La Clinica terapeutica,
G Yanniotis, and J J Eisenring, and G Gauthier, and R Tissot, and J de Ajuriaguerra
[L-dopa with inhibitor in the treatment of parkinsonian syndrome-results of long-term observations].
January 1981, Neurologia i neurochirurgia polska,
G Yanniotis, and J J Eisenring, and G Gauthier, and R Tissot, and J de Ajuriaguerra
Sulphate conjugation and L-dopa treatment of Parkinsonian patients.
August 1973, Nature,
G Yanniotis, and J J Eisenring, and G Gauthier, and R Tissot, and J de Ajuriaguerra
Kaliuretic effect of L-dopa treatment in parkinsonian patients.
January 1977, Acta medica Scandinavica,
G Yanniotis, and J J Eisenring, and G Gauthier, and R Tissot, and J de Ajuriaguerra
Depressive syndromes and L-dopa treatment in Parkinsonian patients.
January 1971, Archivio di psicologia, neurologia e psichiatria,
Copied contents to your clipboard!